What does PHARMACIE G. DENEF do?

PHARMACIE G. DENEF is a logistics company in Binche. Private Limited, started on 28 October 1998, 2 establishments.

What is the address of PHARMACIE G. DENEF?

The registered office of PHARMACIE G. DENEF is located at Rue de Merbes(BUV) 210, 7133 Binche.

Is PHARMACIE G. DENEF still active?

Yes. According to the CBE (29 October 2026) PHARMACIE G. DENEF is active, legal situation “Normale toestand”, started on 28 October 1998.

Is PHARMACIE G. DENEF registered on Peppol?

Yes, PHARMACIE G. DENEF is registered on the Peppol network with ID 0208:0464469355.

What is the enterprise number of PHARMACIE G. DENEF?

The enterprise number of PHARMACIE G. DENEF is BE0464469355.

When was PHARMACIE G. DENEF founded?

PHARMACIE G. DENEF was founded on 28 October 1998.

Who are the directors of PHARMACIE G. DENEF?

According to the 2024 annual accounts, the directors of PHARMACIE G. DENEF are: PHARMACIE DE MARIE SRL.

Is PHARMACIE G. DENEF a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 October 1998; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did PHARMACIE G. DENEF make in 2024?

PHARMACIE G. DENEF posted a profit after taxes of € 31,162 in financial year 2024.

What is the revenue of PHARMACIE G. DENEF?

As a small company, PHARMACIE G. DENEF is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 347,854.

How much does an employee at PHARMACIE G. DENEF earn?

The average wage cost per full-time employee at PHARMACIE G. DENEF was € 62,800 in 2024: staff costs of € 232,196 for 3.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE G. DENEF have?

According to the 2024 annual accounts, PHARMACIE G. DENEF has 3.7 full-time equivalents (FTE).

PHARMACIE G. DENEF (Private Limited) - Binche

Dossier PHARMACIE G. DENEF, printed on 29 October 2026 from databakkes.be/en/0464469355/pharmacie-g-denef. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

PHARMACIE G. DENEF from Binche, company number BE0464469355, closed financial year 2024 with a result of € 31,162 after tax. For that financial year PHARMACIE G. DENEF recorded a gross margin of € 347,854 and equity of € 404,848. Compared with financial year 2023, the result moved from € 126,463 to € 31,162. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.

What it is worth Growing

€ 404,848

▲ 8% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 31,162

▼ 75% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 164,413

▲ 93% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 263,848.

People and assets in 2024

Full-time equivalents

3.7

▲ 0.7 vs 2023

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 232,196

▲ 22% vs 2023

€ 62,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 55,238

▼ 15% vs 2023

Of which on lease € 54,479.

Debts at end 2024

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 221,884

▼ 17% vs 2023

€ 46,495 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 727,988

▲ 48% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 106,642

▲ 31% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Revenue	€ 1,415,509 Revenue 2021: € 1,415,509 First fiscal year in the series	-	-	-
Gross margin	€ 250,132 Gross margin 2021: € 250,132 First fiscal year in the series	€ 408,495 Gross margin 2022: € 408,495 ▲ 63% vs 2021 (€ 250,132) Favourable step	€ 438,917 Gross margin 2023: € 438,917 ▲ 7% vs 2022 (€ 408,495) Favourable step	€ 347,854 Gross margin 2024: € 347,854 ▼ 21% vs 2023 (€ 438,917) Unfavourable step	▼ 21%
Profit after taxes	€ 10,223 Profit after taxes 2021: € 10,223 First fiscal year in the series	€ 165,441 Profit after taxes 2022: € 165,441 ▲ € 155,219 vs 2021 (€ 10,223) Favourable step	€ 126,463 Profit after taxes 2023: € 126,463 ▼ 24% vs 2022 (€ 165,441) Unfavourable step	€ 31,162 Profit after taxes 2024: € 31,162 ▼ 75% vs 2023 (€ 126,463) Unfavourable step	▼ 75%
Equity	€ 81,783 Equity 2021: € 81,783 First fiscal year in the series	€ 247,224 Equity 2022: € 247,224 ▲ 202% vs 2021 (€ 81,783) Favourable step	€ 373,686 Equity 2023: € 373,686 ▲ 51% vs 2022 (€ 247,224) Favourable step	€ 404,848 Equity 2024: € 404,848 ▲ 8% vs 2023 (€ 373,686) Favourable step	▲ 8%
Total debts	€ 750,341 Total debts 2021: € 750,341 First fiscal year in the series	€ 734,947 Total debts 2022: € 734,947 ▼ 2% vs 2021 (€ 750,341) Favourable step	€ 882,657 Total debts 2023: € 882,657 ▲ 20% vs 2022 (€ 734,947) Unfavourable step	€ 1,111,121 Total debts 2024: € 1,111,121 ▲ 26% vs 2023 (€ 882,657) Unfavourable step	▲ 26%
Cash	€ 35,292 Cash 2021: € 35,292 First fiscal year in the series	€ 166,408 Cash 2022: € 166,408 ▲ € 131,115 vs 2021 (€ 35,292) Favourable step	€ 85,333 Cash 2023: € 85,333 ▼ 49% vs 2022 (€ 166,408) Unfavourable step	€ 164,413 Cash 2024: € 164,413 ▲ 93% vs 2023 (€ 85,333) Favourable step	▲ 93%
Land & buildings	€ 301,689 Land & buildings 2021: € 301,689 First fiscal year in the series	€ 386,360 Land & buildings 2022: € 386,360 ▲ 28% vs 2021 (€ 301,689) Unchanged	€ 339,064 Land & buildings 2023: € 339,064 ▼ 12% vs 2022 (€ 386,360) Unchanged	€ 291,768 Land & buildings 2024: € 291,768 ▼ 14% vs 2023 (€ 339,064) Unchanged	▼ 14%
Retained profit	€ -59,217 Retained profit 2021: € -59,217 First fiscal year in the series	€ 106,224 Retained profit 2022: € 106,224 ▲ € 165,441 vs 2021 (€ -59,217) Favourable step	€ 232,686 Retained profit 2023: € 232,686 ▲ 119% vs 2022 (€ 106,224) Favourable step	€ 263,848 Retained profit 2024: € 263,848 ▲ 13% vs 2023 (€ 232,686) Favourable step	▲ 13%
Bank debt	€ 353,147 Bank debt 2021: € 353,147 First fiscal year in the series	€ 309,897 Bank debt 2022: € 309,897 ▼ 12% vs 2021 (€ 353,147) Favourable step	€ 265,864 Bank debt 2023: € 265,864 ▼ 14% vs 2022 (€ 309,897) Favourable step	€ 221,884 Bank debt 2024: € 221,884 ▼ 17% vs 2023 (€ 265,864) Favourable step	▼ 17%
Balance sheet total	€ 832,123 Balance sheet total 2021: € 832,123 First fiscal year in the series	€ 982,171 Balance sheet total 2022: € 982,171 ▲ 18% vs 2021 (€ 832,123) Unchanged	€ 1,256,344 Balance sheet total 2023: € 1,256,344 ▲ 28% vs 2022 (€ 982,171) Unchanged	€ 1,515,969 Balance sheet total 2024: € 1,515,969 ▲ 21% vs 2023 (€ 1,256,344) Unchanged	▲ 21%
Employees (FTE)	3 Employees (FTE) 2021: 3 First fiscal year in the series	2.8 Employees (FTE) 2022: 2.8 ▼ 0.2 vs 2021 (3) Unchanged	3 Employees (FTE) 2023: 3 ▲ 0.2 vs 2022 (2.8) Unchanged	3.7 Employees (FTE) 2024: 3.7 ▲ 0.7 vs 2023 (3) Unchanged	▲ 0.7

Key figures of PHARMACIE G. DENEF, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to PHARMACIE G. DENEF?

What happened at PHARMACIE G. DENEF in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2025 New annual accounts for financial year 2024: profit of € 31,162 (▼ 75% vs 2023). filed late Source: NBB ↗
Aug 24, 2020 New establishment in Le Roeulx. KBO
Dec 22, 1998 New establishment in La Louvière. KBO
Oct 28, 1998 Start of the company according to the CBE. KBO

In short

From € 10,223 profit in 2021 to € 31,162 profit in 2024.

Paid € 70,071 in corporate taxes since 2021.

Best year ever: 2022, with € 165,441 profit.

On average € 94,000 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

PHARMACIE DE MARIE 100%

The stake of PHARMACIE DE MARIE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE G. DENEF

Behind PHARMACIE G. DENEF is PHARMACIE DE MARIE SRL. The shares are held by PHARMACIE DE MARIE (100%).

Directors

According to the 2024 annual accounts

PHARMACIE DE MARIE SRL

Director · represented by Edwin BLAIRON

Also active at: PHARMACIE DE MARIE - INTERNET, PHARMACIE DE MARIE - LE ROEULX CENTRE, PHARMACIE DE MARIE - EPINOIS, PHARMACIE DERASSE

Shareholders

PHARMACIE DE MARIE

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Merbes(BUV) 210

7133 Binche

2.089.709.996

Rue de la Bourse(S-B) 2

7110 La Louvière

Active since 22 December 1998

2.312.587.688

Rue d'Houdeng(R) 194

7070 Le Roeulx

Active since 24 August 2020

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 9 companies are registered at this address.

All companies at this address →

IMMOBILIERE BLAIRON ET CIE

€ 304,970 gross margin · 2024

AUROBAT

€ -9,688 gross margin · 2024

PHARMACIE DE MARIE - EPINOIS same network

€ 459,632 gross margin · 2025

PHARMACIE DE MARIE same network

€ 1.1 million gross margin · 2025

PADEL DES PAPILLONS

€ 53,492 gross margin · 2024

+4 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0464.469.355

VAT number

BE 0464.469.355

Registered office

Rue de Merbes(BUV) 210, 7133 Binche

Names & denominations

PHARMACIE G. DENEF

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

28 October 1998

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE G. DENEF

Financials

What happened to PHARMACIE G. DENEF?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions